Showing results (251-260 of 305) with videos related to
Sort By:
Pageof 31
Nature Reviews. Cancer|May 12, 2019
Going to extremes: determinants of extraordinary response and survival in patients with cancerFlurina A M Saner, Alan Herschtal, Brad H Nelson, et al.Cell Reports|August 28, 2025
T cell receptor repertoire in cell-free DNA as a proxy for tumor infiltrates in patients treated with pembrolizumabShirin Soleimani, Xuan Li, Ben X Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2025
ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uterine Serous CarcinomaJoyce F Liu, Nicoletta Colombo, Amit M Oza, et al.BMC Cancer|March 19, 2025
Immune modulation in solid tumors: a phase 1b study of RO6870810 (BET inhibitor) and atezolizumab (PD-L1 inhibitor)Daniel Marbach, Jurriaan Brouer-Visser, Laura Brennan, et al.Genome Medicine|November 2, 2018
Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivorsS Y Cindy Yang, Stephanie Lheureux, Katherine Karakasis, et al.Translational Oncology|August 24, 2025
Elucidating divergent biology in uterine carcinosarcomaVikas Garg, Stephenie D Prokopec, Simone C Stone, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2023
Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical CancerKathy Han, Jinfeng Zou, Zhen Zhao, et al.Nature Communications|March 16, 2023
Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinomaAinhoa Madariaga, Swati Garg, Nairi Tchrakian, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2020
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition ProgressionStephanie Lheureux, Ana Oaknin, Swati Garg, et al.Journal of Oncology Practice|September 25, 2019
Optimizing the Care of Malignant Bowel Obstruction in Patients With Advanced Gynecologic CancerYeh Chen Lee, Nazlin Jivraj, Lisa Wang, et al.Pageof 31